nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—migraine—Prednisone—ankylosing spondylitis	0.698	1	CpDpCtD
Dihydroergotamine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0335	0.167	CbGbCtD
Dihydroergotamine—ABCB1—Betamethasone—ankylosing spondylitis	0.0218	0.108	CbGbCtD
Dihydroergotamine—ABCB1—Prednisolone—ankylosing spondylitis	0.0215	0.107	CbGbCtD
Dihydroergotamine—ABCB1—Prednisone—ankylosing spondylitis	0.0203	0.101	CbGbCtD
Dihydroergotamine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0201	0.0999	CbGbCtD
Dihydroergotamine—HTR1B—dura mater—ankylosing spondylitis	0.0186	0.492	CbGeAlD
Dihydroergotamine—HTR1D—dura mater—ankylosing spondylitis	0.018	0.477	CbGeAlD
Dihydroergotamine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0152	0.0757	CbGbCtD
Dihydroergotamine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0131	0.065	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0129	0.0641	CbGbCtD
Dihydroergotamine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0127	0.0631	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisone—ankylosing spondylitis	0.0122	0.0605	CbGbCtD
Dihydroergotamine—ABCB1—Methotrexate—ankylosing spondylitis	0.0102	0.0507	CbGbCtD
Dihydroergotamine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00759	0.0378	CbGbCtD
Dihydroergotamine—HTR2B—tendon—ankylosing spondylitis	0.000727	0.0193	CbGeAlD
Dihydroergotamine—ADRA2A—tendon—ankylosing spondylitis	0.000457	0.0121	CbGeAlD
Dihydroergotamine—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00025	0.00395	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000249	0.00394	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000249	0.00393	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.000247	0.0039	CcSEcCtD
Dihydroergotamine—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00024	0.00379	CcSEcCtD
Dihydroergotamine—Visual impairment—Prednisolone—ankylosing spondylitis	0.000239	0.00378	CcSEcCtD
Dihydroergotamine—Muscular weakness—Prednisone—ankylosing spondylitis	0.00023	0.00363	CcSEcCtD
Dihydroergotamine—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000229	0.00362	CcSEcCtD
Dihydroergotamine—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000229	0.00361	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000228	0.00359	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000228	0.00359	CcSEcCtD
Dihydroergotamine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000227	0.00358	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000226	0.00357	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000226	0.00357	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000224	0.00354	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000224	0.00354	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000223	0.00351	CcSEcCtD
Dihydroergotamine—Sweating increased—Prednisone—ankylosing spondylitis	0.00022	0.00347	CcSEcCtD
Dihydroergotamine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00022	0.00347	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000201	0.00317	CcSEcCtD
Dihydroergotamine—Visual impairment—Betamethasone—ankylosing spondylitis	0.0002	0.00315	CcSEcCtD
Dihydroergotamine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.0002	0.00315	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000198	0.00313	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000197	0.00311	CcSEcCtD
Dihydroergotamine—Malaise—Prednisolone—ankylosing spondylitis	0.000195	0.00308	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisolone—ankylosing spondylitis	0.000194	0.00307	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisolone—ankylosing spondylitis	0.000187	0.00295	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000185	0.00291	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000184	0.00291	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisolone—ankylosing spondylitis	0.000182	0.00287	CcSEcCtD
Dihydroergotamine—Malaise—Triamcinolone—ankylosing spondylitis	0.000179	0.00283	CcSEcCtD
Dihydroergotamine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000179	0.00282	CcSEcCtD
Dihydroergotamine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000179	0.00282	CcSEcCtD
Dihydroergotamine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000178	0.00281	CcSEcCtD
Dihydroergotamine—Oedema—Prednisolone—ankylosing spondylitis	0.000176	0.00279	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000175	0.00277	CcSEcCtD
Dihydroergotamine—Shock—Prednisolone—ankylosing spondylitis	0.000174	0.00274	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000172	0.00272	CcSEcCtD
Dihydroergotamine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000172	0.00271	CcSEcCtD
Dihydroergotamine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000171	0.0027	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000171	0.00269	CcSEcCtD
Dihydroergotamine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000169	0.00267	CcSEcCtD
Dihydroergotamine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000169	0.00267	CcSEcCtD
Dihydroergotamine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000169	0.00267	CcSEcCtD
Dihydroergotamine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000168	0.00266	CcSEcCtD
Dihydroergotamine—Flushing—Prednisone—ankylosing spondylitis	0.000168	0.00264	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000167	0.00264	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000167	0.00264	CcSEcCtD
Dihydroergotamine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000167	0.00264	CcSEcCtD
Dihydroergotamine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000167	0.00263	CcSEcCtD
Dihydroergotamine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000166	0.00261	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000163	0.00258	CcSEcCtD
Dihydroergotamine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000163	0.00258	CcSEcCtD
Dihydroergotamine—Malaise—Dexamethasone—ankylosing spondylitis	0.000163	0.00257	CcSEcCtD
Dihydroergotamine—Malaise—Betamethasone—ankylosing spondylitis	0.000163	0.00257	CcSEcCtD
Dihydroergotamine—Oedema—Triamcinolone—ankylosing spondylitis	0.000162	0.00256	CcSEcCtD
Dihydroergotamine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000162	0.00256	CcSEcCtD
Dihydroergotamine—Vertigo—Betamethasone—ankylosing spondylitis	0.000162	0.00256	CcSEcCtD
Dihydroergotamine—Shock—Triamcinolone—ankylosing spondylitis	0.00016	0.00252	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisolone—ankylosing spondylitis	0.00016	0.00252	CcSEcCtD
Dihydroergotamine—Shock—Methylprednisolone—ankylosing spondylitis	0.000159	0.00252	CcSEcCtD
Dihydroergotamine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000159	0.0025	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000158	0.0025	CcSEcCtD
Dihydroergotamine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000158	0.0025	CcSEcCtD
Dihydroergotamine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000158	0.00249	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000157	0.00248	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000157	0.00247	CcSEcCtD
Dihydroergotamine—Hypertension—Betamethasone—ankylosing spondylitis	0.000156	0.00246	CcSEcCtD
Dihydroergotamine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000156	0.00246	CcSEcCtD
Dihydroergotamine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000154	0.00243	CcSEcCtD
Dihydroergotamine—Myalgia—Betamethasone—ankylosing spondylitis	0.000154	0.00243	CcSEcCtD
Dihydroergotamine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000153	0.00242	CcSEcCtD
Dihydroergotamine—Anxiety—Betamethasone—ankylosing spondylitis	0.000153	0.00242	CcSEcCtD
Dihydroergotamine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000152	0.0024	CcSEcCtD
Dihydroergotamine—Discomfort—Betamethasone—ankylosing spondylitis	0.000152	0.0024	CcSEcCtD
Dihydroergotamine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000151	0.00239	CcSEcCtD
Dihydroergotamine—Pain—Prednisolone—ankylosing spondylitis	0.000151	0.00238	CcSEcCtD
Dihydroergotamine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00015	0.00236	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000148	0.00233	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000148	0.00233	CcSEcCtD
Dihydroergotamine—Oedema—Dexamethasone—ankylosing spondylitis	0.000147	0.00232	CcSEcCtD
Dihydroergotamine—Oedema—Betamethasone—ankylosing spondylitis	0.000147	0.00232	CcSEcCtD
Dihydroergotamine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000147	0.00232	CcSEcCtD
Dihydroergotamine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000146	0.00231	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000146	0.0023	CcSEcCtD
Dihydroergotamine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000146	0.0023	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000145	0.0023	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000145	0.0023	CcSEcCtD
Dihydroergotamine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000145	0.0023	CcSEcCtD
Dihydroergotamine—Shock—Betamethasone—ankylosing spondylitis	0.000145	0.00229	CcSEcCtD
Dihydroergotamine—Shock—Dexamethasone—ankylosing spondylitis	0.000145	0.00229	CcSEcCtD
Dihydroergotamine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000145	0.00228	CcSEcCtD
Dihydroergotamine—Agitation—Prednisone—ankylosing spondylitis	0.000144	0.00228	CcSEcCtD
Dihydroergotamine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000144	0.00227	CcSEcCtD
Dihydroergotamine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000144	0.00227	CcSEcCtD
Dihydroergotamine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000143	0.00226	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000143	0.00225	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000142	0.00225	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000142	0.00225	CcSEcCtD
Dihydroergotamine—Malaise—Prednisone—ankylosing spondylitis	0.000142	0.00224	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisone—ankylosing spondylitis	0.000141	0.00223	CcSEcCtD
Dihydroergotamine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000141	0.00222	CcSEcCtD
Dihydroergotamine—Anorexia—Betamethasone—ankylosing spondylitis	0.00014	0.00222	CcSEcCtD
Dihydroergotamine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00014	0.00222	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisolone—ankylosing spondylitis	0.00014	0.00221	CcSEcCtD
Dihydroergotamine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00014	0.00221	CcSEcCtD
Dihydroergotamine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00014	0.0022	CcSEcCtD
Dihydroergotamine—Pain—Triamcinolone—ankylosing spondylitis	0.000139	0.00219	CcSEcCtD
Dihydroergotamine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000138	0.00217	CcSEcCtD
Dihydroergotamine—Hypotension—Betamethasone—ankylosing spondylitis	0.000138	0.00217	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisone—ankylosing spondylitis	0.000136	0.00214	CcSEcCtD
Dihydroergotamine—Chills—Methotrexate—ankylosing spondylitis	0.000135	0.00214	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000134	0.00212	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000134	0.00212	CcSEcCtD
Dihydroergotamine—Myalgia—Prednisone—ankylosing spondylitis	0.000134	0.00211	CcSEcCtD
Dihydroergotamine—Arthralgia—Prednisone—ankylosing spondylitis	0.000134	0.00211	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000134	0.00211	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000133	0.00211	CcSEcCtD
Dihydroergotamine—Anxiety—Prednisone—ankylosing spondylitis	0.000133	0.0021	CcSEcCtD
Dihydroergotamine—Insomnia—Betamethasone—ankylosing spondylitis	0.000133	0.0021	CcSEcCtD
Dihydroergotamine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000133	0.0021	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000132	0.00209	CcSEcCtD
Dihydroergotamine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000132	0.00209	CcSEcCtD
Dihydroergotamine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000132	0.00209	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisone—ankylosing spondylitis	0.000132	0.00209	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00013	0.00205	CcSEcCtD
Dihydroergotamine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00013	0.00205	CcSEcCtD
Dihydroergotamine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00013	0.00205	CcSEcCtD
Dihydroergotamine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000129	0.00204	CcSEcCtD
Dihydroergotamine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000129	0.00203	CcSEcCtD
Dihydroergotamine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000128	0.00203	CcSEcCtD
Dihydroergotamine—Oedema—Prednisone—ankylosing spondylitis	0.000128	0.00202	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000128	0.00202	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000128	0.00202	CcSEcCtD
Dihydroergotamine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000128	0.00202	CcSEcCtD
Dihydroergotamine—Fatigue—Betamethasone—ankylosing spondylitis	0.000127	0.002	CcSEcCtD
Dihydroergotamine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000127	0.002	CcSEcCtD
Dihydroergotamine—Shock—Prednisone—ankylosing spondylitis	0.000126	0.00199	CcSEcCtD
Dihydroergotamine—Pain—Betamethasone—ankylosing spondylitis	0.000126	0.00199	CcSEcCtD
Dihydroergotamine—Pain—Dexamethasone—ankylosing spondylitis	0.000126	0.00199	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisone—ankylosing spondylitis	0.000125	0.00198	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000124	0.00196	CcSEcCtD
Dihydroergotamine—Anorexia—Prednisone—ankylosing spondylitis	0.000122	0.00193	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000122	0.00192	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000121	0.00192	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000121	0.00192	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00012	0.0019	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00012	0.0019	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00012	0.00189	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000119	0.00188	CcSEcCtD
Dihydroergotamine—Malaise—Methotrexate—ankylosing spondylitis	0.000118	0.00187	CcSEcCtD
Dihydroergotamine—Vertigo—Methotrexate—ankylosing spondylitis	0.000118	0.00186	CcSEcCtD
Dihydroergotamine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000117	0.00185	CcSEcCtD
Dihydroergotamine—Urticaria—Betamethasone—ankylosing spondylitis	0.000117	0.00185	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000117	0.00184	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisolone—ankylosing spondylitis	0.000117	0.00184	CcSEcCtD
Dihydroergotamine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000116	0.00184	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000116	0.00184	CcSEcCtD
Dihydroergotamine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000116	0.00184	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000116	0.00184	CcSEcCtD
Dihydroergotamine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000116	0.00184	CcSEcCtD
Dihydroergotamine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000116	0.00183	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisone—ankylosing spondylitis	0.000116	0.00183	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000115	0.00182	CcSEcCtD
Dihydroergotamine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000115	0.00181	CcSEcCtD
Dihydroergotamine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000115	0.00181	CcSEcCtD
Dihydroergotamine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000113	0.00178	CcSEcCtD
Dihydroergotamine—Myalgia—Methotrexate—ankylosing spondylitis	0.000112	0.00176	CcSEcCtD
Dihydroergotamine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000112	0.00176	CcSEcCtD
Dihydroergotamine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000111	0.00176	CcSEcCtD
Dihydroergotamine—Rash—Prednisolone—ankylosing spondylitis	0.000111	0.00176	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000111	0.00176	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000111	0.00175	CcSEcCtD
Dihydroergotamine—Fatigue—Prednisone—ankylosing spondylitis	0.000111	0.00175	CcSEcCtD
Dihydroergotamine—Headache—Prednisolone—ankylosing spondylitis	0.000111	0.00175	CcSEcCtD
Dihydroergotamine—Discomfort—Methotrexate—ankylosing spondylitis	0.00011	0.00174	CcSEcCtD
Dihydroergotamine—Confusional state—Methotrexate—ankylosing spondylitis	0.000108	0.00171	CcSEcCtD
Dihydroergotamine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000107	0.00169	CcSEcCtD
Dihydroergotamine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000107	0.00169	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000106	0.00167	CcSEcCtD
Dihydroergotamine—Asthenia—Betamethasone—ankylosing spondylitis	0.000106	0.00167	CcSEcCtD
Dihydroergotamine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000106	0.00167	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000105	0.00166	CcSEcCtD
Dihydroergotamine—Nausea—Prednisolone—ankylosing spondylitis	0.000105	0.00165	CcSEcCtD
Dihydroergotamine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000104	0.00164	CcSEcCtD
Dihydroergotamine—Pruritus—Betamethasone—ankylosing spondylitis	0.000104	0.00164	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000104	0.00164	CcSEcCtD
Dihydroergotamine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000103	0.00163	CcSEcCtD
Dihydroergotamine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000103	0.00163	CcSEcCtD
Dihydroergotamine—Rash—Triamcinolone—ankylosing spondylitis	0.000102	0.00162	CcSEcCtD
Dihydroergotamine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000102	0.00161	CcSEcCtD
Dihydroergotamine—Anorexia—Methotrexate—ankylosing spondylitis	0.000102	0.00161	CcSEcCtD
Dihydroergotamine—Rash—Methylprednisolone—ankylosing spondylitis	0.000102	0.00161	CcSEcCtD
Dihydroergotamine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000102	0.00161	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisone—ankylosing spondylitis	0.000102	0.00161	CcSEcCtD
Dihydroergotamine—Headache—Triamcinolone—ankylosing spondylitis	0.000102	0.00161	CcSEcCtD
Dihydroergotamine—Headache—Methylprednisolone—ankylosing spondylitis	0.000101	0.0016	CcSEcCtD
Dihydroergotamine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000101	0.0016	CcSEcCtD
Dihydroergotamine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000101	0.0016	CcSEcCtD
Dihydroergotamine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000101	0.00159	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000101	0.00159	CcSEcCtD
Dihydroergotamine—Hypotension—Methotrexate—ankylosing spondylitis	0.0001	0.00158	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	9.77e-05	0.00154	CcSEcCtD
Dihydroergotamine—Dizziness—Betamethasone—ankylosing spondylitis	9.74e-05	0.00154	CcSEcCtD
Dihydroergotamine—Dizziness—Dexamethasone—ankylosing spondylitis	9.74e-05	0.00154	CcSEcCtD
Dihydroergotamine—Insomnia—Methotrexate—ankylosing spondylitis	9.69e-05	0.00153	CcSEcCtD
Dihydroergotamine—Nausea—Triamcinolone—ankylosing spondylitis	9.64e-05	0.00152	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methotrexate—ankylosing spondylitis	9.62e-05	0.00152	CcSEcCtD
Dihydroergotamine—Nausea—Methylprednisolone—ankylosing spondylitis	9.62e-05	0.00152	CcSEcCtD
Dihydroergotamine—Dyspnoea—Methotrexate—ankylosing spondylitis	9.56e-05	0.00151	CcSEcCtD
Dihydroergotamine—Somnolence—Methotrexate—ankylosing spondylitis	9.53e-05	0.0015	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisone—ankylosing spondylitis	9.45e-05	0.00149	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methotrexate—ankylosing spondylitis	9.44e-05	0.00149	CcSEcCtD
Dihydroergotamine—Vomiting—Dexamethasone—ankylosing spondylitis	9.36e-05	0.00148	CcSEcCtD
Dihydroergotamine—Vomiting—Betamethasone—ankylosing spondylitis	9.36e-05	0.00148	CcSEcCtD
Dihydroergotamine—Decreased appetite—Methotrexate—ankylosing spondylitis	9.32e-05	0.00147	CcSEcCtD
Dihydroergotamine—Rash—Dexamethasone—ankylosing spondylitis	9.29e-05	0.00147	CcSEcCtD
Dihydroergotamine—Rash—Betamethasone—ankylosing spondylitis	9.29e-05	0.00147	CcSEcCtD
Dihydroergotamine—Dermatitis—Dexamethasone—ankylosing spondylitis	9.28e-05	0.00146	CcSEcCtD
Dihydroergotamine—Dermatitis—Betamethasone—ankylosing spondylitis	9.28e-05	0.00146	CcSEcCtD
Dihydroergotamine—Fatigue—Methotrexate—ankylosing spondylitis	9.24e-05	0.00146	CcSEcCtD
Dihydroergotamine—Headache—Betamethasone—ankylosing spondylitis	9.23e-05	0.00146	CcSEcCtD
Dihydroergotamine—Headache—Dexamethasone—ankylosing spondylitis	9.23e-05	0.00146	CcSEcCtD
Dihydroergotamine—Asthenia—Prednisone—ankylosing spondylitis	9.2e-05	0.00145	CcSEcCtD
Dihydroergotamine—Pain—Methotrexate—ankylosing spondylitis	9.17e-05	0.00145	CcSEcCtD
Dihydroergotamine—Pruritus—Prednisone—ankylosing spondylitis	9.07e-05	0.00143	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methotrexate—ankylosing spondylitis	8.83e-05	0.00139	CcSEcCtD
Dihydroergotamine—Diarrhoea—Prednisone—ankylosing spondylitis	8.78e-05	0.00139	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	8.76e-05	0.00138	CcSEcCtD
Dihydroergotamine—Nausea—Betamethasone—ankylosing spondylitis	8.75e-05	0.00138	CcSEcCtD
Dihydroergotamine—Nausea—Dexamethasone—ankylosing spondylitis	8.75e-05	0.00138	CcSEcCtD
Dihydroergotamine—Urticaria—Methotrexate—ankylosing spondylitis	8.52e-05	0.00134	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisone—ankylosing spondylitis	8.48e-05	0.00134	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methotrexate—ankylosing spondylitis	8.47e-05	0.00134	CcSEcCtD
Dihydroergotamine—Body temperature increased—Methotrexate—ankylosing spondylitis	8.47e-05	0.00134	CcSEcCtD
Dihydroergotamine—Vomiting—Prednisone—ankylosing spondylitis	8.15e-05	0.00129	CcSEcCtD
Dihydroergotamine—Rash—Prednisone—ankylosing spondylitis	8.09e-05	0.00128	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisone—ankylosing spondylitis	8.08e-05	0.00128	CcSEcCtD
Dihydroergotamine—Headache—Prednisone—ankylosing spondylitis	8.03e-05	0.00127	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methotrexate—ankylosing spondylitis	7.9e-05	0.00125	CcSEcCtD
Dihydroergotamine—Asthenia—Methotrexate—ankylosing spondylitis	7.69e-05	0.00121	CcSEcCtD
Dihydroergotamine—Nausea—Prednisone—ankylosing spondylitis	7.62e-05	0.0012	CcSEcCtD
Dihydroergotamine—Pruritus—Methotrexate—ankylosing spondylitis	7.58e-05	0.0012	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methotrexate—ankylosing spondylitis	7.33e-05	0.00116	CcSEcCtD
Dihydroergotamine—Dizziness—Methotrexate—ankylosing spondylitis	7.09e-05	0.00112	CcSEcCtD
Dihydroergotamine—Vomiting—Methotrexate—ankylosing spondylitis	6.82e-05	0.00108	CcSEcCtD
Dihydroergotamine—Rash—Methotrexate—ankylosing spondylitis	6.76e-05	0.00107	CcSEcCtD
Dihydroergotamine—Dermatitis—Methotrexate—ankylosing spondylitis	6.75e-05	0.00107	CcSEcCtD
Dihydroergotamine—Headache—Methotrexate—ankylosing spondylitis	6.71e-05	0.00106	CcSEcCtD
Dihydroergotamine—Nausea—Methotrexate—ankylosing spondylitis	6.37e-05	0.00101	CcSEcCtD
